|
1
|
Trulock EP, Edwards LB, Taylor DO, Boucek
MM, Keck BM and Hertz MI: International Society for Heart and Lung
Transplantation: Registry of the international society for heart
and lung transplantation: Twenty-third official adult lung and
heart-lung transplantation report-2006. J Heart Lung Transplant.
25:880–892. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang Z, Sharma AK, Linden J, Kron IL and
Laubach VE: CD4+ T lymphocytes mediate acute pulmonary
ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 137:695–702.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma AK, Laubach VE, Ramos SI, Zhao Y,
Stukenborg G, Linden J, Kron IL and Yang Z: Adenosine A2A receptor
activation on CD4+ T lymphocytes and neutrophils attenuates lung
ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 139:474–482.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anvari F, Sharma AK, Fernandez LG, Hranjec
T, Ravid K, Kron IL and Laubach VE: Tissue-derived proinflammatory
effect of adenosine A2B receptor in lung ischemia-reperfusion
injury. J Thorac Cardiovasc Surg. 140:871–877. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Naidu BV, Woolley SM, Farivar AS, Thomas
R, Fraga CH, Goss CH and Mulligan MS: Early tumor necrosis
factor-alpha release from the pulmonary macrophage in lung ischemia
reperfusion injury. J Thorac Cardiovasc Surg. 127:1502–1508. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Maxey TS, Enelow RI, Gaston B, Kron IL,
Laubach VE and Doctor A: Tumor necrosis factor-alpha from resident
lung cells is a key initiating factor in pulmonary
ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 127:541–547.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding JY, Tang L, Xu ST and Wang Q:
Influence of pyrrolidine dithiocarbamate pretreatment on function
of the transplanted rat lung. Zhong Guo Lin Chuang Yi Xue.
17:795–798. 2010.(In Chinese).
|
|
8
|
Kanazawa H, Fujimoto Y, Teratani T,
Iwasaki J, Kasahara N, Negishi K, Tsuruyama T, Uemoto S and
Kobayashi E: Bone marrow-derived mesenchymal stem cells ameliorate
hepatic ischemia reperfusion injury in a rat model. PLoS One.
6:e191952011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Liu S, Li Y, Wang X, Xue W, Ge G
and Luo X: The Role of SDF-1-CXCR4/CXCR7 Axis in the therapeutic
effects of hypoxia-preconditioned mesenchymal stem cells for renal
ischemia/reperfusion injury. PLoS ONE. 7:e346082012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang H, Qu L, Li Y, Gu L, Shi Y, Zhang J,
Zhu W and Li J: Bone marrow mesenchymal stem cells reduce
intestinal ischemia/reperfusion injuries in rats. J Surg Res.
168:127–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang M, Tsai BM, Crisostomo PR and Meldrum
DR: Pretreatment with adult progenitor cells improves recovery and
decreases native myocardial proinflammatory signaling after
ischemia. Shock. 25:454–459. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dharmasaroja P: Bone marrow-derived
mesenchymal stem cells for the treatment of ischemic stroke. J Clin
Neurosci. 16:12–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tögel F, Hu Z, Weiss K, Isaac J, Lange C
and Westenfelder C: Administered mesenchymal stem cells protect
against ischemic acute renal failure through
differentiation-independent mechanisms. Am J Physiol Renal Physiol.
289:F31–F42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen S, Chen L, Wu X, Lin J, Fang J, Chen
X, Wei S, Xu J, Gao Q and Kang M: Ischemia postconditioning and
mesenchymal stem cells engraftment synergistically attenuate
ischemia reperfusion-induced lung injury in rats. J Surg Res.
178:81–91. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun CK, Yen CH, Lin YC, Tsai TH, Chang LT,
Kao YH, Chua S, Fu M, Ko SF, Leu S and Yip HK: Autologous
transplantation of adipose-derived mesenchymal stem cells markedly
reduced acute ischemia-reperfusion lung injury in a rodent model. J
Transl Med. 9:1182011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Németh K, Leelahavanichkul A, Yuen PS,
Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller
BH, Brown JM, et al: Bone marrow stromal cells attenuate sepsis via
prostaglandin E(2)-dependent reprogramming of host macrophages to
increase their interleukin-10 production. Nat Med. 15:42–49. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nauta AJ and Fibbe WE: Immunomodulatory
properties of mesenchymal stromal cells. Blood. 110:3499–3506.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rasmusson I: Immune modulation by
mesenchymal stem cells. Exp Cell Res. 312:2169–2179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ishikane S, Ohnishi S, Yamahara K, Sada M,
Harada K, Mishima K, Iwasaki K, Fujiwara M, Kitamura S, Nagaya N
and Ikeda T: Allogeneic injection of fetal membrane-derived
mesenchymal stem cells induces therapeutic angiogenesis in a rat
model of hind limb ischemia. Stem Cells. 26:2625–2633. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The international society for cellular
therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kabay B, Aytekin FO, Aydin C, Ozer A,
Kabay N, Tekin K, Sungurtekin U, Erdem E and Ozden A:
Interleukin-10 gene therapy attenuates pulmonary tissue injury
caused by mesenteric ischemia-reperfusion in a mouse model. Tohoku
J Exp Med. 207:133–142. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ajuebor MN, Das AM, Virág L, Flower RJ,
Szabó C and Perretti M: Role of resident peritoneal macrophages and
mast cells in chemokine production and neutrophil migration in
acute inflammation: Evidence for an inhibitory loop involving
endogenous IL-10. J Immunol. 162:1685–1691. 1999.PubMed/NCBI
|
|
23
|
Mei SH, Haitsma JJ, Dos Santos CC, Deng Y,
Lai PF, Slutsky AS, Liles WC and Stewart DJ: Mesenchymal stem cells
reduce inflammation while enhancing bacterial clearance and
improving survival in sepsis. Am J Respir Crit Care Med.
182:1047–1057. 2010. View Article : Google Scholar : PubMed/NCBI
|
